Navigation Links
Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease
Date:10/8/2008

e future. Neither can there be any guarantee regarding the long-term impact of a patient's use of Gleevec. In particular, management's expectations regarding Gleevec could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical trial data; unexpected regulatory actions or delays or government regulation generally; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG (NYSE:

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test
2. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia
3. Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS
4. New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R)
5. Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium
6. K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers Grains
7. Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimers
8. Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
9. Eight-Year Melanoma Remission is Among Early Cancer Treatment Results
10. Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients Day
11. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 /CNW/ - Covalon Technologies Ltd. (the ... announces the following financial results for its third quarter of ... 30, 2014: , Revenue of $1,291,378, a 13% ... , Net loss for the quarter of $240,156 compared to ... prior year For the nine months ended ...
(Date:8/27/2014)... 27, 2014  After the February 2014 launch of ... solution for medical practices and management companies, Prime ... new software. "The feedback has been great," ... "The sheer number of demos and new sign-ups is ... for these types of software features." ...
(Date:8/27/2014)... , Aug. 27, 2014 Sinovac Biotech Ltd. (NASDAQ: ... China , today announced the results of the Company,s ... 2014 in Beijing , PRC. The required quorum, ... The Company,s shareholders approved the following proposals:  ... Lam Lo , Simon Anderson , Kenneth Lee ...
Breaking Medicine Technology:Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 3Sinovac Announces Results of 2014 Annual General Meeting of Shareholders 2
... derivative compound series,show highly selective PI3K-inhibition which ... 16, 2007 /PRNewswire-FirstCall/ - AEterna Zentaris,Inc. , ... on,endocrine therapy and oncology, today presented an ... pyridopyrazine derivatives,with high selectivity for PI3K inhibition, ...
... With Improved Potential to,Battle Their Disease, PASADENA, ... Inc., a majority-owned subsidiary of Arrowhead,Research Corporation ... will be featured in a poster presentation ... (AACR) Annual,Meeting. In particular, this poster includes ...
Cached Medicine Technology:AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 2Poster on Cyclosert Drug Delivery Presented at AACR Meeting 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 4
(Date:8/27/2014)... PA (PRWEB) August 27, 2014 What’s ... of this year’s 87th Annual Scripps National Spelling Bee? ... for a tour of internationally renowned Wills Eye Hospital.     ... like to be an ophthalmologist one day. , Wills ... eye surgery and the latest hi-tech visual diagnostic testing. ...
(Date:8/27/2014)... NC. SonaCare Medical, LLC, the global leader in ... 15 HIFU devices over the past twelve months pointing ... company’s ablation technology. , “It is truly exciting ... the past year, especially since we are now heading ... active sales period,” says Mike Klein, CEO of SonaCare ...
(Date:8/27/2014)... -- A new study finds that continuous positive airway ... sleep apnea. CPAP is widely used to treat ... which the airway relaxes and narrows during sleep, causing ... daytime drowsiness. CPAP keeps the airway open ... nose via a mask that is worn during sleep. ...
(Date:8/27/2014)... (HealthDay News) -- Overconfident people are better at convincing ... and therefore are more likely to get promotions and ... researchers added that these "self-deceived" people are also more ... greater risks. And finally, people who underestimate themselves ... to the British researchers. Their findings were published Aug. ...
(Date:8/27/2014)... each receive $100,000 in funding to launch pilot programs ... for patients served by community health centers. The program ... and is part of the group,s effort to reach ... over receiving regular screening for colorectal cancer by 2018. ... are: Port Royal, South Carolina; New Haven, Connecticut; and ...
Breaking Medicine News(10 mins):Health News:Scripps National Spelling Bee Co-Champion and Aspiring Ophthalmologist Coming to Wills Eye Hospital in Philadelphia 2Health News:SonaCare Medical Announces Twelve Months Sales Results of Fifteen HIFU Devices 2Health News:Sleep Apnea Treatment Helps Seniors, Study Finds 2Health News:Overconfident Folks May Blind Others to Their Real Abilities 2Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 2Health News:Pilot program aims to improve cancer screening, specialty care in community health centers 3
... -- Poor memory and problems with other mental skills may be ... suggests. Researchers gave a word recall memory test to 17,851 ... to measure the brain,s executive functioning skills. The participants, who were ... a stroke, were then contacted twice a year for up to ...
... source of cocaine, is speeding up destruction of rainforests ... and animal diversity, scientists are reporting in a new ... for establishing larger protected areas to help preserve biodiversity, ... . Liliana M. Dvalos and colleagues note ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, Feb. ... necessary in women with early breast cancer who also undergo a ... in the Feb. 9 issue of the Journal of the ... sentinel nodes -- those lymph nodes to which the cancer spreads ...
... study from Utrecht and Cambridge Universities has for the ... the tongue in volunteers negatively affects a person,s ability ... findings are published this week in the journal ... addition, the effects of testosterone administration are predicted by ...
... University medical device startup that has developed a system ... closing the beating heart during cardiac surgery has received ... the Georgia Tech/Emory technology and will further develop the ... procedure required for delivering therapeutic devices to the heart ...
... -- An injection of local anesthetic can be made ... researchers report. They reviewed 18 studies that included ... injections led to a "clinically meaningful reduction in pain," ... not; whether the shot was administered subcutaneously (under the ...
Cached Medicine News:Health News:Could Poor Memory Signal Raised Stroke Risk? 2Health News:Cocaine production increases destruction of Colombia's rainforests 2Health News:Removing Many Lymph Nodes in Early Breast Cancer Not Always Needed: Study 2Health News:Removing Many Lymph Nodes in Early Breast Cancer Not Always Needed: Study 3Health News:Extra testosterone reduces your empathy 2Health News:Apica Cardiovascular receives $5.1 million investment for improved heart surgery system 2Health News:Apica Cardiovascular receives $5.1 million investment for improved heart surgery system 3
... assembly. Superb Bi-Polar range of ... Superior pull-out and lever-out strength. ... 44, 48, 52, 56, 60 ... component for all shells. Increased ...
... index. A/P and lateral fins with holes ... medial hole, humeral / glenoid diametral curvature ... textured proximal surface to provide enhanced proximal ... cement, six stem sizes, fifteen head sizes ...
...
...
Medicine Products: